Type 2 diabetes is associated with reduced ATP-binding cassette transporter A1 gene expression, protein and function

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Patel, Dipesh C ^a   Albrecht, Christiane ^c   Pavitt, Darrell ^a   Paul, Vijay ^b   Pourreyron, Celine ^d   Newman, Simon P ^a   Godsland, Ian F ^a   Valabhji, Jonathan ^a   Johnston, Desmond G ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF BERN   (Switzerland)

^d UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN A1; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ABC TRANSPORTER; LIVER X RECEPTOR; MESSENGER RNA; ORPHAN NUCLEAR RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ABCA1 GENE; ABCG1 GENE; ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; FIBROBLAST CULTURE; GENE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; HYPERGLYCEMIA; LEUKOCYTE; LXR ALPHA GENE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PPAR GAMMA GENE; PROTEIN FUNCTION; SKIN FIBROBLAST; CASE CONTROL STUDY; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; FIBROBLAST; GENETICS; GLYCEMIC INDEX; METABOLISM; MIDDLE AGED; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN;

ATP-BINDING CASSETTE TRANSPORTERS; CASE-CONTROL STUDIES; CELLS, CULTURED; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; FIBROBLASTS; GLYCEMIC INDEX; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; ORPHAN NUCLEAR RECEPTORS; PPAR GAMMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN;

EID: 79960809636     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022142     Document Type: Article

References (51)

1. Eschwege E, Richard JL, Thibult N, Ducimetiere P, Warnet JM, et al. (1985) Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels. The Paris Prospective Study, ten years later. Horm Metab Res (Suppl 15): 41-46.
2. Khaw KT, Wareham N, Luben R, Bingham S, Oakes S, et al. (2001) Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk). BMJ 322: 15.
3. Yan SF, Ramasamy R, Naka Y, Schmidt AM, (2003) Glycation, Inflammation, and RAGE: A Scaffold for the Macrovascular Complications of Diabetes and Beyond. Circ Res 93: 1159-1169.
4. Krentz A, (2003) Lipoprotein abnormalities and their consequences for patients with Type 2 diabetes. Diabetes, obesity & metabolism 5: s19.
5. Yamauchi Y, Chang CC, Hayashi M, be-Dohmae S, Reid PC, et al. (2004) Intracellular cholesterol mobilization involved in the ABCA1/apolipoprotein-mediated assembly of high density lipoprotein in fibroblasts. J Lipid Res 45: 1943-1951.
6. Yokoyama S, (2005) Assembly of high density lipoprotein by the ABCA1/apolipoprotein pathway. Curr Opin Lipidol 16: 269-279.
7. Gelissen IC, Harris M, Rye KA, Quinn C, Brown AJ, et al. (2006) ABCA1 and ABCG1 Synergize to Mediate Cholesterol Export to ApoA-I. Arterioscler Thromb Vasc Biol 26: 534-540.
8. Lawn RM, Wade DP, Garvin MR, Wang X, Schwartz K, et al. (1999) The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. J Clin Invest 104: R25-R31.
9. Aiello RJ, Brees D, Bourassa PA, Royer L, Lindsey S, et al. (2002) Increased Atherosclerosis in Hyperlipidemic Mice With Inactivation of ABCA1 in Macrophages. Arteriosclerosis, thrombosis, and vascular biology 22: 630-637.
10. Oram J, (2000) ABCA1-mediated transport of cellular cholesterol and phospholipids to HDL apolipoproteins. Current Opinion in Lipidology 11: 253.
11. Chinetti G, Lestavel S, Bocher V, Remaley AT, Neve B, et al. (2001) PPAR-[α] and PPAR-[γ] activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nat Med 7: 53-58.
12. Uehara Y, Engel T, Li Z, Goepfert C, Rust S, et al. (2002) Polyunsaturated Fatty Acids and Acetoacetate Downregulate the Expression of the ATP-Binding Cassette Transporter A1. Diabetes 51: 2922-2928.
13. Tang C, Kanter JE, Bornfeldt KE, Leboeuf RC, Oram JF, (2010) Diabetes reduces the cholesterol exporter ABCA1 in mouse macrophages and kidneys. J Lipid Res 51: 1719-1728.
14. Passarelli M, Tang C, McDonald TO, O'Brien KD, Gerrity RG, et al. (2005) Advanced glycation end product precursors impair ABCA1-dependent cholesterol removal from cells. Diabetes 54: 2198-2205.
15. Albrecht C, Simon-Vermot I, Elliott JI, Higgins CF, Johnston DG, et al. (2004) Leukocyte ABCA1 gene expression is associated with fasting glucose concentration in normoglycemic men. Metabolism 53: 17-21.
16. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus*. (2003) Follow-up Report on the Diagnosis of Diabetes Mellitus. Diabetes Care 26: 3160-3167.
17. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, et al. (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150: 76-85.
18. Paul V, Meyer HHD, Leidl K, Soumian S, Albrecht C, (2008) A novel enzyme immunoassay specific for ABCA1 protein quantification in human tissues and cells. Journal of lipid research 49: 2259-2267.
19. de Vries R, Groen AK, Perton FG, linga-Thie GM, van Wijland MJA, et al. (2008) Increased cholesterol efflux from cultured fibroblasts to plasma from hypertriglyceridemic type 2 diabetic patients: Roles of pre [β]-HDL, phospholipid transfer protein and cholesterol esterification. Atherosclerosis 196: 733-741.
20. Albrecht C, Soumian S, Amey JS, Sardini A, Higgins CF, et al. (2004) ABCA1 Expression in Carotid Atherosclerotic Plaques. Stroke 35: 2801-2806.
21. Mauerer R, Ebert S, Langmann T, (2009) High glucose, unsaturated and saturated fatty acids differentially regulate expression of ATP-binding cassette transporters ABCA1 and ABCG1 in human macrophages. Exp Mol Med 41: 126-132.
22. Hoang A, Tefft C, Duffy SJ, Formosa M, Henstridge DC, et al. (2008) ABCA1 expression in humans is associated with physical activity and alcohol consumption. Atherosclerosis 197: 197-203.
23. Haghpassand M, Bourassa PA, Francone OL, Aiello RJ, (2001) Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels. J Clin Invest 108: 1315-1320.
24. Zhang Y, McGillicuddy FC, Hinkle CC, O'Neill S, Glick JM, et al. (2010) Adipocyte Modulation of High-Density Lipoprotein Cholesterol. Circulation 121: 1347-1355.
25. van EM, Bos IS, Kaminski WE, Orso E, Rothe G, et al. (2002) Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues. Proc Natl Acad Sci U S A 99: 6298-6303.
26. Forcheron F, Cachefo A, Thevenon S, Pinteur C, Beylot M, (2002) Mechanisms of the Triglyceride- and Cholesterol-Lowering Effect of Fenofibrate in Hyperlipidemic Type 2 Diabetic Patients. Diabetes 51: 3486-3491.
27. Zhou H, Tan KCB, Shiu SWM, Wong Y, (2008) Determinants of leukocyte adenosine triphosphate-binding cassette transporter G1 gene expression in type 2 diabetes mellitus. Metabolism 57: 1135-1140.
28. Mauldin JP, Nagelin MH, Wojcik AJ, Srinivasan S, Skaflen MD, et al. (2008) Reduced Expression of ATP-Binding Cassette Transporter G1 Increases Cholesterol Accumulation in Macrophages of Patients With Type 2 Diabetes Mellitus. Circulation 117: 2785-2792.
29. Sporstol M, Mousavi SA, Eskild W, Roos N, Berg T, (2007) ABCA1, ABCG1 and SR-BI: hormonal regulation in primary rat hepatocytes and human cell lines. BMC Mol Biol 8: 5.
30. Zuo Y, Yancey P, Castro I, Khan W, Motojima M, et al. (2009) Renal Dysfunction Potentiates Foam Cell Formation by Repressing ABCA1. Arterioscler Thromb Vasc Biol 29: 1277-1282.
31. Senanayake S, Brownrigg LM, Panicker V, Croft KD, Joyce DA, et al. (2007) Monocyte-derived macrophages from men and women with Type 2 diabetes mellitus differ in fatty acid composition compared with non-diabetic controls. Diabetes Research and Clinical Practice 75: 292-300.
32. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group (2005) Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes 7. N Engl J Med 353: 2643-2653.
33. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA, (2008) 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes. N Engl J Med 359: 1577-1589.
34. van Dam MJ, de GE, Clee SM, Hovingh GK, Roelants R, et al. (2002) Association between increased arterial-wall thickness and impairment in ABCA1-driven cholesterol efflux: an observational study. Lancet 359: 37-42.
35. Alenezi MY, Marcil M, Blank D, Sherman M, Genest J Jr, (2004) Is the decreased high-density lipoprotein cholesterol in the metabolic syndrome due to cellular lipid efflux defect? J Clin Endocrinol Metab 89: 761-764.
36. Frenais R, Ouguerram K, Maugeais C, Mahot P, Maugere P, et al. (1997) High density lipoprotein apolipoprotein AI kinetics in NIDDM: a stable isotope study. Diabetologia 40: 578-583.
37. Choi JH, Banks AS, Estall JL, Kajimura S, Bostrom P, et al. (2010) Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPAR[g] by Cdk5. Nature 466: 451-456.
38. Kennedy MA, Barrera GC, Nakamura K, Baldan A, Tarr P, et al. (2005) ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. Cell Metab 1: 121-131.
39. Singaraja RR, Visscher H, James ER, Chroni A, Coutinho JM, et al. (2006) Specific mutations in ABCA1 have discrete effects on ABCA1 function and lipid phenotypes both in vivo and in vitro. Circ Res 99: 389-397.
40. Daimon M, Kido T, Baba M, Oizumi T, Jimbu Y, et al. (2005) Association of the ABCA1 gene polymorphisms with type 2 DM in a Japanese population. Biochem Biophys Res Commun 329: 205-210.
41. Villarreal-Molina MT, Flores-Dorantes MT, Rellano-Campos O, Villalobos-Comparan M, Rodriguez-Cruz M, et al. (2008) Association of the ATP-Binding Cassette Transporter A1 R230C Variant With Early-Onset Type 2 Diabetes in a Mexican Population. Diabetes 57: 509-513.
42. Vergeer M, Brunham LR, Koetsveld J, Kruit JK, Verchere CB, et al. (2010) Carriers of Loss-of-Function Mutations in ABCA1 Display Pancreatic B Cell Dysfunction. Diabetes Care.
43. Koseki M, Matsuyama A, Nakatani K, Inagaki M, Nakaoka H, et al. (2009) Impaired insulin secretion in four Tangier disease patients with ABCA1 mutations. J Atheroscler Thromb 16: 292-296.
44. Brunham LR, Kruit JK, Pape TD, Timmins JM, Reuwer AQ, et al. (2007) B-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment. Nat Med 13: 340-347.
45. Sturek JM, Castle JD, Trace AP, Page LC, Castle AM, et al. (2010) An intracellular role for ABCG1-mediated cholesterol transport in the regulated secretory pathway of mouse pancreatic +{pipe} cells. The journal of clinical investigation 120: 2575-2589.
46. Zhu Y, Wang HJ, Chen LF, Fang Q, Yan XW, (2007) Study of ATP-binding cassette transporter A1 (ABCA1)-mediated cellular cholesterol efflux in diabetic golden hamsters. J Int Med Res 35: 508-516.
47. Gao F, Yan T, Zhao Y, Yin F, Hu C, (2010) A possible mechanism linking hyperglycemia and reduced high-density lipoprotein cholesterol levels in diabetes. J Huazhong Univ Sci Technolog Med Sci 30: 318-321.
48. Yu X, Murao K, Imachi H, Li J, Nishiuchi T, et al. (2010) Hyperglycemia suppresses ABCA1 expression in vascular smooth muscle cells. Horm Metab Res 42: 241-246.
49. Khera AV, Cuchel M, de la Llera-Moya M, Rodrigues A, Burke MF, et al. (2011) Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis. New England Journal of Medicine 364: 127-135.
50. Nissen SE, Tsunoda T, Tuzcu EM, Schoenhagen P, Cooper CJ, et al. (2003) Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA 290: 2292-2300.
51. Patel S, Drew BG, Nakhla S, Duffy SJ, Murphy AJ, et al. (2009) Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes. J Am Coll Cardiol 53: 962-971.